Ipekyolu   Report issue

For profit Phase 2
Founded: Turkey (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
2019
NCT03888846
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Ipekyolu Ilac Ltd. Sti

Active Ingredients

Drugs in Phase 2 Trials (2)

colchicine (colbenemid) (1 trial)

pentoxifylline (trental) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Behcet Syndrome (Phase 2)

Oral Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2